BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17689049)

  • 1. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
    Saurer TB; Ijames SG; Carrigan KA; Lysle DT
    Brain Behav Immun; 2008 Jan; 22(1):89-97. PubMed ID: 17689049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
    Saurer TB; Carrigan KA; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Apr; 173(1-2):3-11. PubMed ID: 16364456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations.
    Saurer TB; Ijames SG; Lysle DT
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1040-7. PubMed ID: 19258519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral beta-adrenergic receptor involvement.
    Coussons-Read ME; Dykstra LA; Lysle DT
    Brain Behav Immun; 1994 Sep; 8(3):204-17. PubMed ID: 7865892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement.
    Coussons-Read ME; Dykstra LA; Lysle DT
    J Neuroimmunol; 1994 Dec; 55(2):135-42. PubMed ID: 7829663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pavlovian conditioning of morphine-induced alterations of immune status.
    Coussons ME; Dykstra LA; Lysle DT
    J Neuroimmunol; 1992 Aug; 39(3):219-30. PubMed ID: 1644897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A
    Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dopamine D1-like receptor within the nucleus accumbens in acute food deprivation- and drug priming-induced reinstatement of morphine seeking in rats.
    Sadeghzadeh F; Babapour V; Haghparast A
    Behav Brain Res; 2015; 287():172-81. PubMed ID: 25835321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT.
    Saurer TB; Carrigan KA; Ijames SG; Lysle DT
    J Neuroimmunol; 2004 Mar; 148(1-2):54-62. PubMed ID: 14975586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell.
    Desai SJ; Upadhya MA; Subhedar NK; Kokare DM
    Behav Brain Res; 2013 Jun; 247():79-91. PubMed ID: 23511250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens.
    Kelley AE; Bakshi VP; Fleming S; Holahan MR
    Neuropsychopharmacology; 2000 Oct; 23(4):455-67. PubMed ID: 10989273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine.
    Fecho K; Maslonek KA; Dykstra LA; Lysle DT
    Brain Behav Immun; 1993 Sep; 7(3):253-70. PubMed ID: 8219413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
    Shippenberg TS; Bals-Kubik R; Herz A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):53-9. PubMed ID: 8386244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of nucleus accumbens dopamine D1 receptor blockade on consumption during the first two days of operant self-administration of sweetened ethanol in adult Long-Evans rats.
    Doherty JM; Gonzales RA
    Alcohol; 2015 Sep; 49(6):543-51. PubMed ID: 26142563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists.
    Liao RM
    Pharmacol Biochem Behav; 2008 May; 89(3):367-73. PubMed ID: 18275994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine restores morphine-induced memory deficit through the D1 and D2 dopamine receptor mechanisms in the nucleus accumbens.
    Azizbeigi R; Ahmadi S; Babapour V; Rezayof A; Zarrindast MR
    J Psychopharmacol; 2011 Aug; 25(8):1126-33. PubMed ID: 21616978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjections of a dopamine D1 receptor antagonist into the ventral tegmental area block the expression of cocaine conditioned place preference in rats.
    Galaj E; Manuszak M; Arastehmanesh D; Ranaldi R
    Behav Brain Res; 2014 Oct; 272():279-85. PubMed ID: 25017572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids.
    Lysle DT; Luecken LJ; Maslonek KA
    Brain Behav Immun; 1992 Jun; 6(2):179-88. PubMed ID: 1324030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.